Ledger.Open graph →
SEC Form D · filed September 9, 2025

OWP PHARMACEUTICALS, INC

Offering
$2.4M
Sold
$2.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LISLE, IL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Troy Hammond · Pittsburgh, PADirectorSteve Bourne · NAPERVILLE, ILExecMatt Litfin · LISLE, ILDirectorKurt Florian · NAPERVILLE, ILDirectorScott Boyer · NAPERVILLE, ILExec · DirectorBruce Duncan · NAPERVILLE, ILDirectorTroy Hammond · NAPERVILLE, ILDirectorSteve Bourne · NAPERVILLE, ILExecMatt Litfin · LISLE, ILDirectorKurt Florian · NAPERVILLE, ILDirectorScott Boyer · NAPERVILLE, ILExec · DirectorBruce Duncan · NAPERVILLE, ILDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗